Andrea Harrer

Andrea Harrer is a faculty member with affiliations in the Department of Dermatology and Allergology and Department of Neurology. Her research spans neuroimmunology, dermatoimmunology, and melanoma, focusing on biomarkers in neurology and immune checkpoint inhibition in autoimmune disorders.

• Current focus on cerebrospinal fluid immunology, PD-1 checkpoint mechanisms, and UV radiation in cutaneous melanoma.
• Active in developing diagnostic assays and exploring neuroinflammatory pathways in CNS diseases.

Recent research trends include neuroimmunology (2013–2025), immune checkpoint therapies (2024), and autoimmune CNS disease diagnostics (2011–2018). Her 2025 articles emphasize multiple sclerosis pathogenesis and autoimmune biomarkers.

Projects include leading studies on

• Post-call cognitive impairment in physicians (2018–2020)
• CXCL13-driven immune networks in CNS disease (2018)
• Cerebrospinal fluid immunology (2013)
• Proximity ligation assays for antibody quantification (2011–2012)

Education and Future Work details are not explicitly stated in the text, but her ongoing research in 2025 suggests continued exploration of immunological mechanisms in neurological and dermatological contexts.